statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This indicator may be signaling LMAT's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

LeMaitre Vascular (LMAT, $67.01) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024

Teladoc Health, Inc. TDOC is well-poised to grow on the back of rising access fees and the continuous adoption of telehealth services. Its expanding product offerings are likely to bring in more...

Here's Why Investors Should Hold Teladoc (TDOC) Stock Now

BURLINGTON, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 23rd Annual...

LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference

LeMaitre Vascular (LMAT, $65.38) entered Uptrend as Momentum indicator ascends above 0 level on Mar 25, 2024

Citigroup Inc. decreased its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT  Free Report) by 47.2% in the third quarter, according to its most recent Form 13F filing with the...

Citigroup Inc. Lowers Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LeMaitre Vascular, Inc. (NASDAQ:LMAT  Get Free Report) has received an average recommendation of Moderate Buy from the six research firms that are covering the stock, MarketBeat...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Analysts

In recent trading, shares of LeMaitre Vascular Inc (LMAT) have crossed above the average analyst 12-month target price of 67.17, changing hands for 67.34/share. When a stock reaches the...

LeMaitre Vascular Reaches Analyst Target Price

LeMaitre Vascular, Inc. (NASDAQ:LMAT  Get Free Report) Director John A. Roush sold 7,500 shares of the companys stock in a transaction dated Thursday, March 7th. The shares were sold at...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director John A. Roush Sells 7,500 Shares of Stock

On 3/13/24, MDU Resources Group Inc (MDU), LeMaitre Vascular Inc (LMAT), and Valley National Bancorp (VLY) will all trade ex-dividend for their respective upcoming dividends. MDU Resources Group Inc...

Ex-Dividend Reminder: MDU Resources Group, LeMaitre Vascular and Valley National Bancorp

LeMaitre Vascular, Inc. (NASDAQ:LMAT  Get Free Report) Director John A. Roush sold 7,500 shares of the firms stock in a transaction that occurred on Thursday, March 7th. The shares were...

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director John A. Roush Sells 7,500 Shares

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Watchers	435
52-Wk Low	$44.27
52-Wk High	$79.41

Volume	89,777.00
52-Wk High	$79.41
52-Wk Low	$44.27

LMAT Lemaitre Vascular Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community